{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:11:15Z","timestamp":1791465075465,"version":"4.3.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The diagnostic performance of a prospective, systematic screening strategy for COVID-19 associated pulmonary aspergillosis (CAPA) during the COVID-19 pandemic was investigated. Patients with COVID-19 admitted to the ICU were screened for CAPA twice weekly by collection of tracheal aspirate (TA) for Aspergillus culture and PCR. Subsequently, bronchoalveolar lavage (BAL) sampling was performed in patients with positive screening results and clinical suspicion of infection. Patient data were collected from April 2020\u2013February 2022. Patients were classified according to 2020 ECMM\/ISHAM consensus criteria. In total, 126\/370 (34%) patients were positive in screening and CAPA frequency was 52\/370 (14%) (including 13 patients negative in screening). CAPA was confirmed in 32\/43 (74%) screening positive patients who underwent BAL sampling. ICU mortality was 62% in patients with positive screening and confirmed CAPA, and 31% in CAPA cases who were screening negative. The sensitivity, specificity, positive and negative predictive value (PPV &amp; NPV) of screening for CAPA were 0.71, 0.73, 0.27, and 0.95, respectively. The PPV was higher if screening was culture positive compared to PCR positive only, 0.42 and 0.12 respectively. CAPA was confirmed in 74% of screening positive patients, and culture of TA had a better diagnostic performance than PCR. Positive screening along with clinical manifestations appeared to be a good indication for BAL sampling since diagnosis of CAPA was confirmed in most of these patients. Prospective, systematic screening allowed to quickly gain insight into the epidemiology of fungal superinfections during the pandemic and could be applicable for future pandemics.<\/jats:p>","DOI":"10.1093\/mmy\/myae028","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T05:30:40Z","timestamp":1711603840000},"source":"Crossref","is-referenced-by-count":4,"title":["Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4091-2955","authenticated-orcid":false,"given":"Rebecca","family":"van\u00a0Grootveld","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center , Leiden , The Netherlands"},{"name":"Department of Medical Microbiology, Albert Schweitzer Hospital , Dordrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-4948","authenticated-orcid":false,"given":"Judith","family":"van\u00a0Paassen","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C J","family":"Claas","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heerdink","sequence":"additional","affiliation":[{"name":"Directorate of Education (DOO), Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed J","family":"Kuijper","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G J","family":"de\u00a0Boer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Center , Leiden , The Netherlands"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha T","family":"van\u00a0der\u00a0Beek","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"LUMC-COVID-19 Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"2024051515321132000_bib1","doi-asserted-by":"crossref","first-page":"ofac081","DOI":"10.1093\/ofid\/ofac081","article-title":"Coronavirus Disease 2019-associated pulmonary aspergillosis: reframing the debate","volume":"9","author":"Clancy","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024051515321132000_bib2","doi-asserted-by":"crossref","first-page":"154272","DOI":"10.1016\/j.jcrc.2023.154272","article-title":"Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy","volume":"76","author":"van\u00a0Grootveld","year":"2023","journal-title":"J Crit Care"},{"key":"2024051515321132000_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensive Care Med"},{"key":"2024051515321132000_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis","volume":"28","author":"Kariyawasam","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2024051515321132000_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/myc.13259","article-title":"Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate","volume":"64","author":"van\u00a0Grootveld","year":"2021","journal-title":"Mycoses"},{"key":"2024051515321132000_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024051515321132000_bib7"},{"key":"2024051515321132000_bib8","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"2024051515321132000_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"2024051515321132000_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2023.01.041","article-title":"A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages","volume":"129","author":"Swets","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2024051515321132000_bib11","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024051515321132000_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/s41591-020-0997-y","article-title":"Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands","volume":"26","author":"Oude\u00a0Munnink","year":"2020","journal-title":"Nat Med"},{"key":"2024051515321132000_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/myc.13545","article-title":"Active screening of COVID-19-associated pulmonary aspergillosis with serum beta-glucan and endotracheal aspirates galactomannan and fungal culture","volume":"66","author":"Pavone","year":"2023","journal-title":"Mycoses"},{"key":"2024051515321132000_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024051515321132000_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2024051515321132000_bib16","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis(1)","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg Infect. Dis."},{"key":"2024051515321132000_bib17","doi-asserted-by":"crossref","first-page":"e0122921","DOI":"10.1128\/JCM.01229-21","article-title":"Aspergillus test profiles and mortality in critically ill COVID-19 patients","volume":"59","author":"Erg\u00fcn","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024051515321132000_bib18","doi-asserted-by":"crossref","first-page":"e0216921","DOI":"10.1128\/jcm.02169-21","article-title":"Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?","volume":"60","author":"Delli\u00e8re","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2024051515321132000_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cid\/ciy698","article-title":"The complex case of Aspergillus and mortality","volume":"68","author":"van\u00a0de\u00a0Peppel","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024051515321132000_bib20","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.cmi.2021.06.025","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?","volume":"27","author":"Fekkar","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024051515321132000_bib21","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: a systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"key":"2024051515321132000_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcrc.2020.07.002","article-title":"Late histopathologic characteristics of critically ill COVID-19 patients: different phenotypes without evidence of invasive aspergillosis, a case series","volume":"59","author":"Flikweert","year":"2020","journal-title":"J Crit Care"},{"key":"2024051515321132000_bib23","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024051515321132000_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"van\u00a0de\u00a0Veerdonk","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024051515321132000_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myae028\/57105816\/myae028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/5\/myae028\/57677635\/myae028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/5\/myae028\/57677635\/myae028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:32:47Z","timestamp":1715787167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae028\/7636487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae028","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,3,27]]},"article-number":"myae028"}}